SCHEMBL20148164

SCHEMBL20148164

CC(C)Oc1ccc(/C=N\O)c(F)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AMY1A P0DUB6 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 2/20 0.40
LMNA P02545 5/20 0.40
RAB9A P51151 3/20 0.39
POLB P06746 2/20 0.39
MAPT P10636 2/20 0.39
PARP10 Q53GL7 1/20 0.38
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP1B1 Q16678 1/20 0.36
CPS1 P31327 1/20 0.36
NPC1 O15118 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
ALDH1A3 P47895 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150797 1.00 AMY1A (0.41) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL8692623 0.81 AMY1A (0.59) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL18502970 0.81 AMY1A (0.59) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL8692626 0.81 AMY1A (0.59) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL14285929 0.78 ALDH1A3 (0.52) KMT2AKDM4EALDH1A1POLBPARP10
SCHEMBL20148167 0.77 HPGD (0.48) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL20151704 0.77 HPGD (0.48) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL20148146 0.75 PDE2A (0.44) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL20150815 0.75 PDE2A (0.44) AMY1AL3MBTL1KMT2AKDM4EALDH1A1
SCHEMBL14116467 0.75 TYR (0.43) L3MBTL1KMT2AKDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors FORUM PHARMACEUTICALS, INC. 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134696-A1 Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors CHRNA7, CHRNA5, CHRNA2 AMY1A 1411/4885L3MBTL1 3492/4885KMT2A 1939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.